Stem Cell Therapy for Sensorineural Hearing Loss - How Do Glial Cells Interact With Auditory Stem Cells in the Peripheral Auditory System?
干细胞疗法治疗感音神经性听力损失 - 神经胶质细胞如何与周围听觉系统中的听觉干细胞相互作用?
基本信息
- 批准号:MR/L001829/1
- 负责人:
- 金额:$ 27.18万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Fellowship
- 财政年份:2013
- 资助国家:英国
- 起止时间:2013 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Clinical Background of ResearchHearing problems are an extremely significant public health issue. Almost 10 million people in Britain suffer with hearing impairment and forecasts suggest this will rise to 15 million by the year 2030. 'Sensorineural hearing loss' accounts for almost 90% of all hearing problems and occurs as a result of irreversible damage to the inner ear, especially the cochlea, where sound vibrations are converted into nerve signals. Although electrical devices such as Cochlear Implants have been used successfully to help patients of all ages suffering with severe sensorineural hearing loss, the limitations of such devices are gradually becoming apparent. Regenerative medicine provides some hope of biological therapies which may be able to treat sensorineural hearing loss with greater effect than current treatments with electrical devices. In a recent major breakthrough, our laboratory has demonstrated the ability of stem cells to repair and restore function of damaged hearing nerves in animal models of sensorineural hearing loss. This project will build on our previous work by understanding how stem cells integrate with a damaged hearing system. Importance of this Research'Glial Cells' are cells which maintain the health of nerve cells. It is well known that nerve damage results in the activation and multiplication of 'glial cells'. In some parts of the nervous system, this process of glial cell multiplication can help with the repair of damaged nerves, but in other parts, such as the brain and spinal cord, the multiplication of glial cells represents scarring which limits further damage to nerves, but also prevents repair. It has recently been discovered that damage to the hearing nerve also causes multiplication of glial cells, but it remains unclear if this represents an environment which would either support repair or whether it represents scarring. This would obviously have implications on the ability for stem cells to repair the damaged hearing nerve. Hence, understanding the relationship between the glial cells of the hearing system and stem cells is a key factor in the quest to translate this therapy to patients. Aims of this ResearchThe aims of this project are to understand the ways in which stem cells communicate with glial cells, and to illustrate whether the response of glial cells to damage of the hearing nerve represents scarring, or whether it represents a favourable environment for and stem cells to repair the hearing nerve. We will then demonstrate how transplanted auditory stem cells integrate with glial cells in animal models of deafness. Research PlanThe project will be conducted in two phases. The first phase will consist of culturing stem cells programmed for the auditory system to check if they are capable of producing their own glial-like cells. The stem cells will then be cultured alongside glial cells from the cochlea, which will allow the interaction between the two cell types to be studied. The second phase will consist of determining whether stem cells are able to repair the damaged hearing nerve despite the multiplication of glial cells. This will involve performing careful analysis of the glial cell types in the damaged hearing nerve and how stem cells interact with them. The information gathered from the previous phase will help in describing this relationship. Host InstitutionThis project will be undertaken at the Centre for Stem Cell Biology at the University of Sheffield which has international recognition as a centre of excellence for research into Stem Cells. The centre has pioneered the use of stem cells to the inner ear and has all the necessary facilities to carry out this project.
研究的临床背景听力问题是一个极其重要的公共卫生问题。英国有近1000万人患有听力障碍,预测显示,到2030年,这一数字将上升到1500万。“感音神经性听力损失”占所有听力问题的近90%,是由于内耳,特别是耳蜗,声音振动转换为神经信号的不可逆损伤而发生的。尽管诸如Coplanar植入物的电气设备已成功地用于帮助所有年龄段的重度感音神经性听力损失患者,但此类设备的局限性逐渐变得明显。再生医学为生物疗法提供了一些希望,这种生物疗法可能能够治疗感音神经性听力损失,其效果比目前使用电气设备的治疗更好。在最近的一项重大突破中,我们的实验室已经证明了干细胞在感觉神经性听力损失动物模型中修复和恢复受损听力神经功能的能力。这个项目将建立在我们以前的工作,了解干细胞如何与受损的听力系统整合。这项研究的重要性“神经胶质细胞”是维持神经细胞健康的细胞。众所周知,神经损伤导致“胶质细胞”的活化和增殖。在神经系统的某些部分,这种神经胶质细胞增殖的过程可以帮助修复受损的神经,但在其他部分,如大脑和脊髓,神经胶质细胞的增殖代表疤痕,这限制了对神经的进一步损伤,但也阻止了修复。最近发现,听觉神经的损伤也会导致神经胶质细胞的增殖,但目前还不清楚这是否代表了一个支持修复的环境,或者它是否代表了疤痕。这显然会影响干细胞修复受损听觉神经的能力。因此,了解听力系统的神经胶质细胞和干细胞之间的关系是寻求将这种疗法转化为患者的关键因素。本研究的目的本项目的目的是了解干细胞与神经胶质细胞沟通的方式,并说明神经胶质细胞对听觉神经损伤的反应是否代表瘢痕形成,或者它是否代表干细胞修复听觉神经的有利环境。然后,我们将展示移植的听觉干细胞如何与耳聋动物模型中的神经胶质细胞整合。研究计划研究计划将分两个阶段进行。第一阶段将包括培养为听觉系统编程的干细胞,以检查它们是否能够产生自己的神经胶质样细胞。然后将干细胞与耳蜗的神经胶质细胞一起培养,这将允许研究两种细胞类型之间的相互作用。第二阶段将包括确定干细胞是否能够修复受损的听觉神经,尽管神经胶质细胞增殖。这将涉及对受损听觉神经中的胶质细胞类型以及干细胞如何与它们相互作用进行仔细分析。从上一阶段收集的信息将有助于描述这种关系。主办机构本项目将在谢菲尔德大学的干细胞生物学中心进行,该中心是国际公认的干细胞研究卓越中心。该中心率先将干细胞用于内耳,并拥有实施该项目的所有必要设施。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ali Mallick其他文献
The psychosocial effects of hearing aid use in children
- DOI:
10.1016/j.ijsu.2013.06.264 - 发表时间:
2013-10-01 - 期刊:
- 影响因子:
- 作者:
Ali Qureishi;Ali Mallick;Matthew Warrilow;Thomas Maggs;David Parker - 通讯作者:
David Parker
Ali Mallick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
- 批准号:QN25H220002
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
- 批准号:
- 批准年份:2024
- 资助金额:15.0 万元
- 项目类别:省市级项目
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造
血干细胞生成中的作用及机制研究
- 批准号:TGY24H080011
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于In-cell NMR策略对“舟楫之剂”桔梗中引经药效物质的快速发现研究
- 批准号:82305053
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
面向Cell-Free网络的协同虚拟化与动态传输
- 批准号:62371367
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Cell-in-cell促进曲妥珠单抗耐药乳腺癌细胞转移的作用与分子机制
- 批准号:82373069
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于Multi-Pass Cell的高功率皮秒激光脉冲非线性压缩关键技术研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于定点突变膜受体Cell-free合成生物色谱新方法的PDGFRβ抑制剂筛选和结合位点分析
- 批准号:82273886
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
FLRT3抑制异质性cell-in-cell结构形成机制及细胞免疫调节作用研究
- 批准号:
- 批准年份:2022
- 资助金额:51 万元
- 项目类别:面上项目
基于Cell-SELEX 的磁珠富集技术与LAMP 联合构建的梅毒螺旋体核酸检测方法及其临床应用
- 批准号:2021JJ30609
- 批准年份:2021
- 资助金额:0.0 万元
- 项目类别:省市级项目
相似海外基金
Establishment of cell therapy using tissue stem cells derived from perifascial areolar tissue (PAT)
使用来自筋膜周围乳晕组织(PAT)的组织干细胞建立细胞疗法
- 批准号:
23K09089 - 财政年份:2023
- 资助金额:
$ 27.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cell Therapy Program with Scale-up cGMP Manufacturing of Human Corneal Stromal Stem Cells
细胞治疗计划,扩大人类角膜基质干细胞的 cGMP 生产
- 批准号:
10720562 - 财政年份:2023
- 资助金额:
$ 27.18万 - 项目类别:
Highly Purified Mesenchymal Stem Cell Therapy for Neuropathy of Congenital Metabolic Disorders Involved on Mitochondria
高纯化间充质干细胞治疗涉及线粒体的先天性代谢紊乱神经病
- 批准号:
23H02876 - 财政年份:2023
- 资助金额:
$ 27.18万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Phase 2 clinical trial of a novel T cell therapy following bridging therapy with hypomethylating agents for relapsed AML patients post-stem cell transplant
干细胞移植后复发性 AML 患者使用低甲基化药物桥接治疗后新型 T 细胞疗法的 2 期临床试验
- 批准号:
10761513 - 财政年份:2023
- 资助金额:
$ 27.18万 - 项目类别:
Precision Apheresis: stem cell isolation from patients with sickle cell disease for gene therapy using high-throughput microfluidics
精密血浆分离术:使用高通量微流控技术从镰状细胞病患者中分离干细胞进行基因治疗
- 批准号:
10723247 - 财政年份:2023
- 资助金额:
$ 27.18万 - 项目类别:
Applying induced pluripotent stem cell derived endothelial cells to regenerative therapy in chronic limb threatening ischemia
将诱导多能干细胞衍生的内皮细胞应用于慢性肢体威胁性缺血的再生治疗
- 批准号:
10701387 - 财政年份:2023
- 资助金额:
$ 27.18万 - 项目类别:
Induced pluripotent stem cell-derived dendritic cell vaccine therapy genetically modified to express neo-antigen
诱导多能干细胞衍生的树突状细胞疫苗疗法经过基因改造以表达新抗原
- 批准号:
23K08160 - 财政年份:2023
- 资助金额:
$ 27.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of stem cell motility mechanism and its application to regeneration and cancer therapy
阐明干细胞运动机制及其在再生和癌症治疗中的应用
- 批准号:
23K07820 - 财政年份:2023
- 资助金额:
$ 27.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Conference: Stem Cells, Cell Therapy and Bioengineering in Lung Biology and Diseases 2023
会议:肺生物学和疾病中的干细胞、细胞治疗和生物工程 2023
- 批准号:
2327935 - 财政年份:2023
- 资助金额:
$ 27.18万 - 项目类别:
Standard Grant
An Innovative Two-Step Therapeutic Strategy to Maximize the Effect of Stem Cell Therapy for Post-Traumatic Osteoarthritis
创新的两步治疗策略可最大限度地发挥干细胞治疗创伤后骨关节炎的效果
- 批准号:
10643442 - 财政年份:2023
- 资助金额:
$ 27.18万 - 项目类别: